Search
for
Sort by
Research 391–420 of 1000+
- A Murine Model for Inducing and Manipulating Hair Follicle Regression (Catagen): Effects of Dexamethasone and Cyclosporin A
- A SHORT COMMUNICATION ON FORMULATION AND EVALUATION OF DEPILATORIES
- Abstracts from the Symposium on the Pathophysiology of Hair Growth Organized by the Institute of Dermatology at the Royal Society of Medicine, 29 October 1987
- Bioactivities, isolation and purification methods of polysaccharides from natural products: A review
- Is COVID-19 Gender-sensitive?
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Hormone replacement therapy and the skin
- Obesity and polycystic ovary syndrome
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- The role of nuclear hormone receptors in cutaneous wound repair
- Androgen receptors and their biology
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- The Androgen Receptor Antagonizes Wnt/β-Catenin Signaling in Epidermal Stem Cells
- Regulation of masculinization: androgen signalling for external genitalia development
- Eupafolin nanoparticles protect HaCaT keratinocytes from particulate matter-induced inflammation and oxidative stress
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Epidermal Stem Cells Manipulated by pDNA-VEGF165/CYD-PEI Nanoparticles Loaded Gelatin/β-TCP Matrix as a Therapeutic Agent and Gene Delivery Vehicle for Wound Healing
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- SlPHL1, a MYB‐CC transcription factor identified from tomato, positively regulates the phosphate starvation response
- Improving selective androgen receptor modulator discovery and preclinical evaluation